John Toigo and Kate Gardner in our Corporate Team, recently acted as the Australian lawyers for Anteo Diagnostics Limited (ASX:ADO), an Australian listed
biotech company, in its acquisition of 100% of DIAsource ImmunoAssays S.A., a Belgium based diagnostics company, which operates in 75 countries.
This is a transformational acquisition for Anteo, providing it with an established global distribution platform, manufacturing capabilities and a significantly broadened product range. As part of this transaction John and Kate also advised Anteo on its capital raising activities (including a rights issue) to fund the acquisition.
Our greatest asset is our talented and committed people – they enjoy what they do and value the opportunity to work together and with our clients. Our people are from diverse backgrounds and approach their work with intellectual rigour and enthusiasm.